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Penetration Pathways Induced by Low-Frequency
Sonophoresis with Physical and Chemical Enhancers:
Iron Oxide Nanoparticles versus Lanthanum Nitrates
Sang Eun Lee1,5, Ki Ju Choi2,5, Gopinathan K. Menon3, Hyun Jung Kim1, Eung Ho Choi4, Sung Ku Ahn4
and Seung Hun Lee1
Low-frequency sonophoresis (LFS) has been shown to disrupt the structure of stratum corneum (SC) lipid
bilayers and enhance SC permeability. In this study, we examined the penetration pathway of lanthanum nitrate
(LaNO3) tracer in viable epidermis after combined treatment of LFS and tape stripping (TS), as a physical
enhancer, or oleic acid (OA) application, as a chemical enhancer, using transmission electron microscopy (TEM).
As a positive control, we visualized the passive diffusion pathway of LaNO3 and iron oxide (Fe3O4) nanoparticles
after the incision of hairless mouse skin. Next, we applied LFS immediately after TS or OA application and
visualized the penetration pathway of LaNO3. Each treatment showed restricted penetration to the SC–stratum
granulosum (SG) interface or upper SG layer. However, the additional application of LFS induced diffuse
intracellular distribution of LaNO3 throughout the viable epidermis. Quantitative analysis also revealed that
combined treatment significantly increases LaNO3 penetration into viable epidermis when compared with each
treatment. Our ultrastructural findings show the synergistic effect of LFS and TS or OA application on
transdermal drug delivery. We also found that this combined treatment enhances the penetration of LaNO3
through the viable epidermis through an intracellular pathway.
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INTRODUCTION
Low-frequency sonophoresis (LFS) is a method of enhancing
skin permeability to drugs using ultrasound at a low
frequency (20–100 kHz). LFS has been shown to enhance
transdermal transport of a variety of molecules, including
insulin (Kost et al., 2000), morphine (Monti et al., 2001),
glucose (Merino et al., 2003), lidocaine (Becker et al., 2005),
heparin, and tetanus toxoid vaccine (Ogura et al., 2008). As
stratum corneum (SC) is the most significant barrier to
transdermal delivery (Elias, 1983), many ultrastructural
studies have focused on analyzing the permeation pathways
through the SC during LFS, using various visualization
methods. It is now accepted that lacunae spaces that are
present in normal lipid bilayers of SC and LFS increase the
spatial frequency of lacunae, which possibly leads to the
formation of a well-connected three-dimensional porous
network in the SC (Paliwal et al., 2006). These dilated lacuna
spaces during LFS are considered the putative pathway for
permeation of polar and nonpolar molecules across the SC
(Menon and Elias, 1997; Tezel et al., 2002, 2003). Recently,
these ultrastructural modifications of the SC during LFS have
been illustrated using quantum dots as tracer nanoparticles
(Paliwal et al., 2006).
Recently, therapeutic applications of ultrasound-mediated
transdermal drug transport have been extended to various
areas, including chemotherapy, tissue engineering, and gene
therapy (Ogura et al., 2008). For therapeutic efficacy, a deep
penetration of drugs not only into the SC layers but also into
the viable epidermis and capillary plexus may be important.
However, although many studies have been performed to
identify the LFS-induced penetration pathways within the SC
(Menon and Elias, 1997; Paliwal et al., 2006), the LFS-
induced penetration pathways in the viable epidermis are
largely unanalyzed. For these reasons, in this analysis, we
primarily focused on the penetration pathway of tracers in the
viable skin layers. Previous studies have shown that the
effects of sonophoresis act synergistically with various other
physicochemical enhancement methods on transdermal drug
transport (Mitragotri and Kost, 2004). Among the chemical
enhancers, oleic acid (OA) has been suggested to act by
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extracting a fraction of the endogenous SC membrane
components, and by promoting phase separation within SC
lipids, thereby decreasing the barrier permeability function
(Naik et al., 1995). Tape stripping (TS) may enhance
penetration by physically reducing SC thickness and facil-
itating the delivery of tracers percutaneously. From these
results, we hypothesized that LFS with chemical or physical
enhancer could be used to deliver the tracers deep into the
viable epidermis allowing us to analyze the penetration
pathway of tracers in the viable skin layers. On the basis of
these assumptions, OA application and TS were performed in
combination with LFS as a chemical and physical enhancer,
respectively. Then, we analyzed and visualized the
effects of these combination treatments on the permeation
of an electron-dense tracer, lanthanum nitrate (LaNO3),
through the viable epidermis using transmission electron
microscopy (TEM). As the aim of this study was to elucidate
the penetration pathway of tracers across the viable
epidermis after these combined treatments, it was necessary
to perform the passive diffusion experiments with an incision
technique for delivering tracers across an SC barrier as a
positive control. Recently, nano-sized particles, whose
dimensions areo100nm, have received significant attention
for biomedical and cosmetic applications; however, toxico-
logical issues, including the probability of penetration into
skin and the possible intrinsic toxicity, remain major
concerns (Jin and Ye, 2007; Nohynek et al., 2008; Baroli,
2009). Moreover, a recent study, using light transmission
microscope and TEM (Baroli et al., 2007), showed that
metallic nanoparticles (maghemite and iron nanoparticles),
smaller than 10 nm, were able to passively penetrate into
human full-thickness skin through the SC lipidic matrix and
aggregated SC-viable epidermis junction, occasionally reach-
ing the viable epidermis. For these reasons, we also analyzed
the passive diffusion pathway of iron oxide (Fe3O4) nano-
particles across the viable epidermis and compared it with
the pathway of LaNO3.
RESULTS
Nanoparticle characterization
TEM visualization revealed that Fe3O4 nanoparticles were
uniform in size and as small as 4.7–10.6 nm (average
8.67±2.8 nm in Figure 1). Fe3O4 nanoparticles were
found as electron-dense individual particles and had
a uniform cubic shape. In the absence of any surface
modification, iron oxide nanoparticles in this study have no
surface charge.
Ultrastructural changes of stratum corneum after
low-frequency sonophoresis (LFS)
We observed the ultrastructural changes on the surface of SC
after treatment with low-frequency ultrasound using scanning
electron microscopy and TEM. Approximately 1- to 2-mm-
sized pores were observed on the surface of corneocytes after
5minutes of LFS in the scanning electron microscopy images
(arrow heads, Figure 2b). A TEM study to assess the
penetration of LaNO3 in the SC showed that in the absence
of ultrasound, LaNO3 was found to be restricted to the top
layers of SC (Figure 2c). After the application of ultrasound,
LaNO3 was distributed inside the corneocytes of the upper-
most two layers of SC in the TEM images (Figure 2d).
To assess the LFS-induced ultrastructural changes in the lipid
lamellae, we next examined the LFS-treated epidermis using
ruthenium tetroxide postfixation. In the tightly packed lipid
bilayers of the SC, discrete elongated defects (dilated
lacunae) were found after LFS (arrow, Figure 2e). Occasion-
ally, rolled-up lipids were found in the dilated lacunae
(arrow, Figure 2f).
Different diffusion pathway of LaNO3 and Fe3O4 nanoparticle
in the viable epidermis
To identify and visualize the passive diffusion pathway within
the underlying nucleated layers of epidermis, we made a
superficial incision over the back of the mouse and then
applied LaNO3 or Fe3O4. TEM images revealed a longitudinal
fissure formed by an incision extended to the SG which
measured approximately 1 mm in width. LaNO3 was found to
spread from the fissure into the adjacent keratinocytes (Figure
3a). The LaNO3, which was immediately adjacent to the
incision site, showed diffuse intracellular distribution and
was also detected in the intercellular spaces (Figure 3b). In
contrast to the area near the injury, in the area 30 mm distant
from the incision site, LaNO3 was observed primarily in the
intercellular spaces (arrow, Figure 3c). In the area adjacent
from the injury, both LaNO3 and Fe3O4 showed a similar
pattern of distribution. As shown in the uppermost SC, both
tracers were found in the cytoplasm of corneocytes and in the
intercellular lipid lamellae (Figures 4a and 5a). However, in
the area 30 mm distant from the incision, the penetration
pattern of the two kinds of tracers differed. As shown in the
6.74 nm
7.27 nm
8.74 nm
9.19 nm
8.58 nm
Figure 1. TEM micrograph of iron oxide nanoparticles.
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nucleated viable epidermis, LaNO3 was observed to be
localized in the intercellular spaces (Figure 4b). In contrast,
Fe3O4 nanoparticles were observed to be diffusely distributed
in the intracellular spaces (Figure 5b).
Permeation pathways of LaNO3 after LFS combined with other
penetration enhancement methods
To penetrate LaNO3 deeply into the viable epidermis and
assess the permeation pathway in the viable epidermis, we
used two different penetration enhancement methods,
including chemical enhancer and TS before the application
of ultrasound. LaNO3 applied to tape-stripped skin was
observed to permeate across the SC into the SC–SG interface
and occasionally into the upper SG layer (Figure 6a–c). This
observation represents a defective barrier function because of
the removal of SC components by TS. We found that in the
uppermost SC, LaNO3 was presented inside the corneocytes,
whereas in the underlying layers of lower SC and upper SG,
LaNO3 was localized in the intercellular domains (Figure 6b
and c). However, when the tape-stripped skin was exposed to
ultrasound in the presence of LaNO3, the tracers were
observed to be uniformly distributed throughout the epider-
mis. LaNO3 penetrated into the intracellular and intercellular
spaces extending to the stratum basalis layer of the viable
epidermis (Figure 6d–f). Next, we used a chemical enhancer.
The effects of OA-induced skin penetration enhancement
have been previously reported using the lanthanum perfusion
method. Consistent with the previous report, we observed
that LaNO3 extended into the intercellular spaces of the
SC and into the SC–SG interface in OA-treated epidermis
(Figure 7a). In the uppermost SC, the tracers penetrated inside
the corneocytes in OA-treated epidermis in a manner similar
to that observed in tape-stripped skin (Figure 7b). When the
OA-treated skin was exposed to ultrasound in the presence of
LaNO3, the tracers were observed to be uniformly distributed
in the intracellular and intercellular domains throughout the
Figure 2. The ultrastructural changes on the SC surface and the penetration
pathways of lanthanum nitrates after treatment with LFS, and TEM images of
SC after treatment with LFS using ruthenium tetroxide fixation. (a) After
5minutes of treatment with LFS, 1- to 2-mm-sized pores (b, arrowheads) were
observed on the SC surfaces, which were not observed on the normal SC
surface. (b) The scanning electron microscopy findings on the SC surface of
mouse skin treated with LFS. (c) TEM findings in the SC after application of
LaNO3. In the absence of LFS, LaNO3 was found to be restricted to the
intercellular spaces of the upper SC. (d) In contrast, after 5minutes of
treatment with LFS, LaNO3 was found in the intercellular and intracellular
domains of the corneocytes in the upper SC. (e, arrow) After 5minutes of
treatment of LFS, 2- to 4-mm expansions in lacunae were observed in the
widened intercellular spaces of the SC. (f, arrow) In some sections, rolled-up
lipids were also observed in the dilated lacunae. Scale bar¼ 2mm.
SC
SC
SG
SG
SG
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Figure 3. Transmission electron micrographs of mouse skin sections after
application of LaNO3 after cutting a vertical incision. (a) After cutting the
back skin of the mouse with a sharp blade, we applied LaNO3 and observed
the passive diffusion pathways of LaNO3 with TEM. A longitudinal fissure
formed by incision extended to the stratum spinosum and measured about
1mm in width. LaNO3 was found to spread from the fissure into the adjacent
tissue. (b) Enlarged view of the region near the incision site. LaNO3
immediately adjacent to the incision site showed diffuse cytoplasmic
distribution and is also detected in the intracellular spaces. (c, arrow) In
contrast with the region near the incision site, at 30mm distance from the
incision site, LaNO3 was observed primarily in the intercellular spaces.
Scale bar¼ 1 mm.
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epidermis, similar to the distribution seen in TS/LFS-treated
skin (Figure 7d–f).
Quantitative analysis of the penetration of LaNO3
The number density and area density of the electron-dense
dots of LaNO3, which penetrated into the SC, significantly
increased in LFS-treated skin, tape-stripped skin, OA-treated
skin, TS/LFS-treated skin, and OA/LFS-treated skin compared
to those of controls (Po0.005) (Figure 8a and b). The number
density of LaNO3, which penetrated into the viable epidermis
from the SB to SG layers, was about 6.34-fold and 28.13-fold
higher in OA/LFS-treated skin compared with that of OA-
treated skin (P¼0.0025) and LFS-treated skin (P¼0.0038),
respectively. The number density of LaNO3, which pene-
trated into the viable epidermis, was about 4.04- and 41.88-
fold higher in TS/LFS-treated skin compared with that of the
tape-stripped skin (P¼ 0.0047) and LFS-treated skin
(P¼0.0015), respectively (Figure 8c). The area density of
LaNO3, which penetrated into the viable epidermis, was
about 1.84- and 18.4-fold higher in OA/LFS-treated skin
compared with that of the OA-treated skin (P¼ 0.0068) and
LFS-treated skin (P¼ 0.0019), respectively. The area density
of LaNO3, which penetrated into the viable epidermis, was
about 1.56- and 19-fold higher in TS/LFS-treated skin
compared with that of the tape-stripped skin (P¼0.0053)
and LFS-treated skin (P¼ 0.0025), respectively (Figure 8d).
These results suggest that the combined treatment of LFS and
OA application or TS synergistically enhance the delivery of
tracers into the viable epidermis.
DISCUSSION
Consistent with previous observations, we found dilated
lacuna spaces within the intercorneocyte lipid lamellae after
LFS using TEM. The surface of SC after LFS application
showed several 1- to 2-mm-sized pores in the scanning
electron microscopy image. It has been shown that asymme-
trical cavitation bubble collapse near the SC surface produces
an acoustic microjet that might directly penetrate into the SC
and disrupt the structure (Mitragotri and Kost, 2004). Initial
damage in the membrane of the outmost cell layer by an
acoustic microjet leads to the replacement of the original cell
contents by nearby water and induces the formation of
microbubbles in the second cell layer. Pores on the surface of
SC, which are shown in Figure 2, can be thought of as the
passing marks of a microjet. We also showed that LFS
delivered LaNO3 into the intracellular domain of corneocytes
at the uppermost two layers of SC in the TEM images and that
direct permeation at the upper SC might be because of
asymmetric bubble collapse at the SC surface and rupture of
the membrane of the next deeper cells.
In this study, we used three different techniques to
enhance skin permeability, including LFS, TS as a physical
enhancer, and OA application as a chemical enhancer.
A single application of each technique showed limited
penetration of LaNO3, which penetrated the skin across the
SC and reached and aggregated to the SC-SG junction and
occasionally presented in the upper layers of SG, suggesting
that in addition to the SC barrier, the junction between the SC
and the viable epidermis is also an important barrier to skin
penetration. The tight junctions in the granular layer, non-
degraded corneodesmosomes, and more tightly compacted
SC near the viable epidermis might form a structural barrier at
the SC-viable epidermis junction (Kierszenbaum, 2002;
Baroli et al., 2007). In the passive diffusion experiments,
which we used as a positive penetration control, we showed
that both LaNO3 and Fe3O4 nanoparticles permeated the
viable epidermis by passive diffusion into the SB layer, after
disruption of the SC barrier with a superficial incision. Our
results also showed that in the area adjacent to the incision
site, both LaNO3 and Fe3O4 showed diffuse intracellular and
intercellular distributions; however, in the area distant from
the incision, LaNO3 was observed primarily in the inter-
cellular spaces. On the other hand, Fe3O4 was observed to be
diffusely distributed in the intracellular spaces. This different
pattern of diffusion through the viable epidermis between
LaNO3 and Fe3O4 could be explained by the different
physicochemical characteristics of the two tracers. The
dimension or particle size has been suggested as the most
important property to influence nanoparticle permeation and
diffusion through the skin (Baroli et al., 2007; Rouse et al.,
2007). The dimensions of LaNO3 and Fe3O4 nanoparticles
were 2–10 and 4.6–10 nm, respectively, from the TEM
measurement. Although the possibility and reversibility of
SC
SG
SS
Figure 4. Transmission electron micrographs of mouse skin sections after
application of LaNO3 after making an incision and diagram of a passive
diffusion pathway of LaNO3. After cutting the skin with a sharp blade, we
applied LaNO3 and visualized the distribution of tracers immediately adjacent
to the incision site and at 30mm distance from the incision site with TEM. (a)
In the SC, near the incision sites, LaNO3 was observed in the intracellular
domains of corneocytes (a, arrows) (inset shows the enlarged view of
corneocytes). (b) In contrast, at 30mm distance from the incision site, LaNO3
was observed primarily in the intercellular spaces (b, arrows) (inset shows the
enlarged view of SC–SG interface). (c) Diagram shows the passive diffusion
pathway of LaNO3. Scale bar¼ 0.5 mm.
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aggregation of these particles in vivo cannot be ruled out, we
could assume that both particles had similar dimensions.
Along with their dimensions, the shape, superficial properties
such as charges and polarity, and the stability of nanoparti-
cles may further affect the penetration route and the depth of
penetration across the skin (Baroli, 2009). As both tracer
solutions were identical in concentration and contact time,
one of the possible explanations for this difference in
penetration route is surface charge. It was found that, owing
to the charge of the lipid membrane, intermolecular forces
SC
SS
Figure 5. Transmission electron micrographs of mouse skin sections after application of Fe3O4 nanoparticles after making an incision and diagram of a passive
diffusion pathway of Fe3O4. After cutting the skin with a sharp blade, we applied Fe3O4 and visualized the distribution of Fe3O4 immediately adjacent to the
incision site and at 30mm distance from the incision site with TEM. (a) In the SC, near the incision sites, Fe3O4 was observed in the intracellular domains
of corneocytes (a, arrow) and within the intercellular lipid lamellae (a, closed arrow) (inset shows the enlarged view of intercellular lipid lamellae). (b) In
contrast, at 30 mm distance from the incision site, Fe3O4 was observed to be uniformly distributed in the intracellular spaces (b, arrows) (inset shows the enlarged
view of intracellular spaces). (c) Diagram shows the passive diffusion pathway of Fe3O4 nanoparticles. Scale bar¼ 0.5 mm.
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Figure 6. Transmission electron micrographs of mouse skin sections after tape stripping or LFS following tape stripping in the presence of LaNO3.We applied
LaNO3 to tape-stripped mouse skin or skin treated with LFS after TS. (a) In the tape-stripped skin, TEM images show the LaNO3 penetrating into the
SC and upper SG. (b) In the enlarged view of the SC, LaNO3 was present within the intracellular domains of corneocytes at the upper SC and also in the
intercellular spaces. (c) In the enlarged view of the SC–SG interface, LaNO3 was present at the SC–SG interface and intercellular spaces at the upper SG. (d) After
TS/LFS treatment, LaNO3 was observed to be diffusely distributed in the underlying epidermis, even in the SB layer. (e) In the enlarged view of the SC, LaNO3
was present within the intracellular domains of corneocytes at the upper SC and also in the intercellular spaces. (f) In the enlarged view of the underlying
epidermis, LaNO3 was observed to be diffusely distributed in the intracellular and intercellular spaces. Scale bars¼ 2 mm (a, d), 1mm (b, c, e, f).
www.jidonline.org 1067
SE Lee et al.
Skin Penetration Pathways by Low-Frequency Sonophoresis
occurred between penetrants and cellular lipid bilayers
during the penetration process and a high partial charge on
the penetrant increased these intermolecular interactions and
retarded penetration (Degim, 2005). For this reason, biolo-
gical membranes are impermeable to most polar or charged
molecules, but permeable to nonpolar compounds. There-
fore, LaNO3, the well-known ionic tracer, is expected to be
unable to penetrate into the intercellular lipid bilayers
SC
SC SC
SC
SC
SC
SG
SG
SG
SS
SB
SG
SS
SB
Figure 7. Transmission electron micrographs of mouse skin sections after OA application and LFS following OA application in the presence of LaNO3. We
applied LaNO3 to OA-treated mouse skin or skin treated with LFS after OA application. (a) In the OA-treated skin, TEM images show the LaNO3 penetrating into
the SC and SC–SG interface. (b) In the enlarged view of the SC, LaNO3 was present within the intracellular domains of corneocytes at the upper SC and also in
the intercellular spaces. (c) In the enlarged view of the SC–SG interface, LaNO3 was limited to the SC–SG interface. (d) After treatment with LFS following OA
application, LaNO3 was observed to be diffusely distributed in the underlying epidermis, even in the SB layer. (e) In the enlarged view of the SC, LaNO3 was
present within the intracellular domains of corneocytes at the upper SC and also in the intercellular spaces. (f) In the enlarged view of the underlying epidermis,
LaNO3 was observed to be diffusely distributed in the intracellular and intercellular spaces. Scale bars¼2 mm (a, d), 1 mm (b, c, e, f).
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Figure 8. Quantitative analysis of the penetration of LaNO3. (a) The number density and (b) area density of LaNO3 penetrated into the SC increased in
LFS-treated skin, tape-stripped skin, OA-applied skin, TS/LFS-treated skin, and OA/LFS-treated skin compared with controls (Po0.005). (c) The number density
of LaNO3 penetrated into the viable epidermis from the SB to the SG layer increased in TS/LFS-treated skin compared with that of the tape-stripped skin
(P¼0.0047) and LFS-treated skin (P¼ 0.0015). OA/LFS-treated skin showed significantly increased number density of LaNO3 penetrated into the viable
epidermis compared with that of the OA-treated skin (P¼ 0.0025) and LFS-treated skin (P¼ 0.0038). (d) The area density of LaNO3 penetrated into the viable
epidermis increased in TS/LFS-treated skin compared with that of the tape-stripped skin (P¼ 0.0053) and LFS-treated skin (P¼ 0.0025). OA/LFS-treated skin
showed significantly increased area density of LaNO3 penetrated into the viable epidermis compared with that of the OA-treated skin (P¼ 0.0068) and
LFS-treated skin (P¼ 0.0019) (**significant difference; Po0.01).
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because of its surface charge, thereby spreading primarily
in the intercellular spaces, whereas Fe3O4 nanoparticles
with no surface modification, which did not present
surface charge, could penetrate into the cell membrane
and spread diffusely through the intracellular domains. Iron
oxide nanoparticles have attracted interest because of their
potential applications in biomedicine, including imaging,
magnetic-induced target drug delivery, magnetic transfection
of cells, tumor destruction by hyperthermia, photodynamic
therapy, and biosensors for early detection of cancer,
diabetes, and atherosclerosis (Penn et al., 2003; Gupta and
Gupta, 2005; Neuberger et al., 2005; Wang et al., 2007;
Bechet et al., 2008). With appropriate surface coatings,
magnetic nanoparticles have also been used as cosmetic
agents (Baroli, 2009). Our results suggest that if iron oxide
nanoparticles o10 nm are accidentally in contact with the
barrier-impaired skin or intentionally applied to diseased skin
for therapeutic purposes, they could readily diffuse the viable
epidermis through intracellular routes. However, care should
be taken when generalizing our results using iron oxide
nanoparticles without any surface modification to the
clinically applied iron oxide-based multifunctional nanopar-
ticles, because the surface property of the nanoparticle
changes with functional ligands and the penetration mechan-
ism of the nanoparticle is affected by these modified surface
properties.
In our study, we found that TS or OA application
pretreatment that was followed by LFS application enhanced
the penetration depth of LaNO3 into the SB layer compared
with the penetration depth after each treatment of LFS, TS, or
OA application, which showed limited penetration of LaNO3
to the SC-viable epidermis junction or upper layer of the SG.
These results are in agreement with previous studies showing
the synergistic effects between LFS and various enhancers on
transdermal drug transport and suggest that LFS combined
with chemical or physical enhancers is as effective in
enhancing skin permeability as direct skin injury, such as
incision. Consistent with these electron microscopic observa-
tions, quantitative analysis of tracer penetration also revealed
the synergistic effects of LFS with TS or OA application
(Figure 8). Considering the possibility of LaNO3 aggregation
in vivo, we analyzed and quantified both the number
density and area density of lanthanum nitrates in TEM
images. LFS application on tape-stripped skin increased the
number density of LaNO3 penetrated into the viable
epidermal layers by 41.88- and 4.04-fold, respectively,
compared with the penetration after the application of either
LFS or TS alone. The area density of LaNO3 penetrated
into the viable epidermis after TS/LFS treatment showed
similar synergistic enhancement (19- and 1.56-fold increase,
respectively, compared with the penetration following the
application of either LFS or TS alone). The physical
penetration enhancement methods, such as microscission,
thermal poration, radiofrequency ablation, and microneedle
application, have been shown to increase skin permeability
to various therapeutic compounds by creating micron-scale
pathways within the skin, thereby breaching the SC barrier
temporarily (Prausnitz and Langer, 2008). TS could also
reduce the physical barrier of the skin by reducing SC
thickness and may facilitate the intraepidermal drug delivery.
LFS has also been shown to target its effects on the SC barrier
by disrupting lipid bilayers of SC, and therefore the
combination treatment of TS and LFS could act synergistically
on disrupting the SC barrier and enhancing the skin
permeability. Our results also showed that the application
of LFS in combination with OA synergistically enhances the
number and area density of LaNO3 penetrated into the viable
epidermis compared with each treatment alone. OA pre-
treatment immediately followed by application of LFS
increased the number density of LaNO3 penetrated into the
viable epidermis by 28.13- and 6.34-fold, respectively,
compared with the penetration after the application of either
LFS or OA application alone. The area density of LaNO3
penetrated into the viable epidermis after OA/LFS treatment
showed similar synergistic enhancement (18.4- and 1.84-fold
increase, respectively, compared with the penetration after
the application of either LFS or OA application alone). These
results are in agreement with previous studies that have
suggested that LFS acts synergistically with various chemical
penetration enhancers. Mitragotri et al. (2000) reported that
sodium lauryl sulfate enhanced skin permeability to mannitol
synergistically in combination with ultrasound. Johnson et al.
(1996) reported that the combined application of linoleic
acid and ethanol with ultrasound increased corticosteroid
flux by up to 13,000-fold compared with passive flux, which
was higher than that induced by each treatment alone.
El-Kamel et al. (2008) reported the synergistic effect of the
chemical enhancers, 1% OA or 1% dodecylamine, and
sonophoresis on testosterone transdermal delivery. The
proposed mechanisms for these synergistic effects of ultra-
sound and chemical enhancers on transdermal drug
transport are that the cavitation produced by ultrasound
may induce mixing and facilitate the dispersion of the
chemical enhancer with SC lipids (Johnson et al., 1996;
Mitragotri, 2000). OA has been used as a skin penetration
enhancer through the mechanisms of lipid fluidization and
lipid phase separation (Naik et al., 1995). In addition, a
recent ultrastructural study has shown that OA application
resulted in the formation of expanded lacunae and distinct
disorganization of the SC lipid structures in vivo, suggesting
that OA may enhance skin permeability by dual mechanisms
involving SC lipid bilayer perturbation and lacunae formation
(Jiang and Zhou, 2003).
It is interesting that the penetration depth and the
penetration patterns of LaNO3 in the SC were similar;
however, the penetration pathways of LaNO3 in the viable
epidermis showed different patterns between passive diffu-
sion with a primarily intercellular pathway and combined LFS
treatment with TS or OA with a primarily intracellular
pathway. This difference in penetration pathway of LaNO3
in the viable epidermis may be explained by a cavitation
effect of LFS. LFS is shown to generate cavitation—the
formation, oscillation, and collapse of bubbles in an
ultrasound pressure field (Rao and Nanda, 2009). The
cavitation inside the skin is now thought to be the most
important mechanism in LFS-induced skin permeability (Tang
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et al., 2002). In the SC, LFS-induced cavitation bubbles
interact with SC and generate localized shock waves and
liquid microjets directed at the SC surface, resulting in
ultrastructural modification of the structure of lipid bilayers in
the SC as well as increased lacunae spaces and a theoretical
three-dimensional porous network (Tezel and Mitragotri,
2003; Paliwal et al., 2006). In addition, the collapse of
cavitation bubbles can generate forced convection in the
presence of ultrasound (Morimoto et al., 2005). On the
basis of the concept that cavitations are generated as a
result of dissolved gases, we expect that in contrast with
the SC, which is not a liquid and is too thin to allow
large bubbles, the underlying viable epidermis may possess
more abundant and well-formed cavities during LFS. The
transient collapse of these cavitation bubbles interacting with
cells produces high local pressures and temperatures
(Frizzell, 1988). This inertial cavitation has been suggested
to have a significant role on LFS-mediated membrane
permeabilization by two possible mechanisms, including
shock waves and shear stresses (Miller et al., 1996; Sundaram
et al., 2003). In addition, keratinocytes in the viable
epidermis showed a more decreased cell diameter and
reduced barrier properties than SC, and therefore the effects
of cavitation may influence a broader area (Kushner et al.,
2007). From this context, we hypothesized that in the
underlying viable epidermis, cavitation effects may increase
the membrane permeability of keratinocytes, driving the
molecules into both intercellular and intracellular spaces,
and resulting in deep penetration.
In this study, we provide morphologic evidence for the
synergistic effect of LFS and other penetration enhancers
on skin permeability and visualized an ultrastructural path-
way of LaNO3 and Fe3O4 within the viable epidermal
layers. We also visualized the ability of combined treatment
of LFS with TS or OA to enhance the penetration of LaNO3
through an intracellular pathway, which supports the
morphologic basis for the use of LFS as a method for cellular
drug delivery. Finally, it should also be noted that our data
obtained with hairless mice skin do not necessarily translate
into human skin because the penetration of nanosized
molecules may be different among species with different
skin architecture and composition. Our results are summar-
ized in Figure 9.
MATERIALS AND METHODS
Animals
Adult hairless mice were purchased from the animal laboratory of
Yonsei University and were 8- to 12-week-old females at the time of
Figure 9. The penetration pathways of LaNO3 after combined treatment of LFS and physical or chemical enhancer. (a) When LaNO3 is applied to
untreated skin, LaNO3 penetration is restricted to the intercellular spaces in the uppermost SC. (b) When LaNO3 is applied to tape-stripped skin or
(c) OA-treated skin, the penetration is restricted to the SC, SC–SG interface, and occasionally in the upper SG layers with primarily intercellular distribution.
(d) In LFS-treated skin in the presence of LaNO3, the penetration is extended to the upper SG layer with primarily intercellular distribution. (e) In TS/LFS-treated
skin or in (f) OA/LFS-treated skin, LaNO3 is shown to be uniformly distributed in the full-thickness epidermis (SC–SB layers) with both intracellular and
intercellular spaces.
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study. The use of mice was approved by the institutional review
board of the Yonsei University College of Medicine.
Nanoparticle synthesis and characterization
All synthesis processes of the nanoparticles were carried out in a
nitrogen–filled environment by using standard airless techniques.
Commercial Iron (II) acetylacetonate, 1,2-hexadecanediol, lauric
acid, dodecyl amine, and diphenyl ether, purchased from Aldrich
(Milwaukee, WI), were used without further purification. Hydro-
phobic iron oxide nanoparticles were synthesized through thermal
decomposition of Fe(acac)3 (acac¼ acetylacetonate) in a hot organic
solvent by modified procedures previously reported. Fe(acac)3
(2mmol), 1,2-hexadecanediol (10mmol), lauric acid (6mmol),
dodecylamine (6mmol), and diphenyl ether were mixed and
magnetically stirred under a flow of nitrogen. A sample of 6 nm
Fe3O4 nanoparticles dispersed in hexane was added. The mixture
was first heated at 150 1C for 30minutes to remove hexane, and then
at 200 1C for 1 hour. Under a blanket of nitrogen, the mixture was
further heated to reflux for 30minutes. The black-colored mixture
was cooled to room temperature by removing the heat source. Iron
oxide nanoparticles were suspended in hexane at a concentration of
5mgml1. The stock solution (5mgml1) of iron nanoparticles was
mixed with 0.3M oleic acid-stabilizing ligands (1:1 molar ratios of
iron oxide to oleic acid) for steric stabilization in nonpolar solutions.
The working concentration of the iron nanoparticle was 2.5mgml1.
The size and morphology of iron oxide nanoparticles were observed
using TEM.
Ultrasound application
Adult female hairless mice were anesthetized with chloral hydrate.
Lanthanum nitrate tracer only was applied to the negative control
group for 5minutes. To analyze the penetration pathway of the
tracer after LFS, the solution containing lanthanum nitrate tracers
was used as a coupling medium. The 3% lanthanum nitrate solution
was prepared by dissolving lanthanum nitrate in 0.1M phosphate
buffer. A total of 1% toluidine blue was added to the lanthanum
nitrate solution to identify the location of LFS-induced localized
transport regions. The working concentration of lanthanum
nitrate solution was 1.5% (15mgml1). 50 ml tracer solutions were
applied to the backs of hairless mice. The site then immediately
received 5minutes of 800mW per cm2, 25-kHz continuous wave
ultrasound. The probe was placed directly on the skin surface and
the tracer solution was changed every 20 seconds during treatment
by turning off the ultrasound. The ultrasonic intensity was measured
using an UW-4 ultrasound wattmeter (Fluke Biomedical, Carson
City, NV), as described by Tezel et al. (2001). Immediately after the
exposure period, the tracer solution was removed from the treated
area by washing with distilled water and was then dried gently with
a cotton swab. After ultrasound application, no visible irritation was
observed and blue-colored patches were observed on the skin
surface, representing the potential tracer localized transport regions,
in which lanthanum nitrates and toluidine blue were concentrated.
In the combined treatment of LFS and physical enhancement, the
treatment site was tape stripped and then received LFS treatment
with the identical frequency, intensity, and duration. In the
combined treatment of LFS and chemical enhancer, OA was
dissolved at 0.3 M in distilled water. OA solution was topically
applied to the dorsal skin of mice with OA solution-soaked cotton
balls for 30minutes at 5-minute intervals and completely removed
from the treated site by distilled water and wiped with a paper towel.
The application site then received LFS treatment with the identical
frequency, intensity, and duration.
For the visualization and comparison of pathways and the extent
of percutaneous penetration of lanthanum nitrates among all treated
groups, the same volume and concentration of tracer solutions were
applied to each treated site with the same contact time: 50 ml tracer
solutions containing 3% lanthanum nitrate were applied every
20 seconds for 5minutes.
Passive diffusion pathway studies
As the aim of this study was to elucidate the penetration pathway of
the tracer across the viable epidermis after combined treatment with
LFS and other penetration enhancement methods, it was necessary to
perform passive diffusion experiments with an incision technique for
delivering tracers across an SC barrier instead of LFS or other
penetration enhancement methods as a positive control. A super-
ficial incision was made through the dorsal skin of mice with a sharp
scalpel, and 50 ml tracer solutions containing lanthanum nitrates
were applied to the site that was breached by scalpel incision.
The second aim of this study was to analyze and compare the
transport pathways of two different tracers across the viable
epidermis, including lanthanum nitrate and Fe3O4 nanoparticle.
For purposes of comparison, we applied 50 ml tracer solutions
containing Fe3O4 nanoparticle to the dorsal skin of mice that were
incised with a scalpel in the same way.
Transmission electron microscopy
After treatment, the skin tissues were cut into 1–2mm3 pieces and
immediately fixed in Karnovsky’s fixative for 2 hours at 4 1C. The
samples were then washed in 0.1 M phosphate buffer and post-fixed
in 1% osmium tetroxide (EMS, Hatfield, PA). For ruthenium tetroxide
post-fixation, the specimens were post-fixed in 0.25% ruthenium
tetroxide (EMS), 0.1 M phosphate buffer for 45minutes at room
temperature in the dark. Subsequently, the samples were dehydrated
in a graded series of ethanol, embedded in a low-viscosity
epon–epoxy mixture, and sectioned (UCT, Leica, Germany). Thin
sections were unstained and examined under a transmission electron
microscope (H-7600, Hitachi, Japan) operating at 80 kV.
Scanning electron microscopy
For scanning electron microscopy, specimens with 0.5–1.0 cm2
thickness were cut and dried at a critical point drier (HCP-2, Hitachi,
Japan) mounted on an aluminum stub. The specimens were then
Pt-Pd coated (E-1030, Hitachi, Japan) and examined with a scanning
electron microscope (S-4700, Hitachi, Japan).
Penetrated LaNO3 quantification
Penetrated LaNO3 was quantified using image analysis tools (ImageJ,
National Institutes of Health). Images were processed by taking fast
Fourier transform and/or by convolving images, followed by thresh-
olding to extract tracer spots from the images. The processed images
thus obtained only represented tracers, which were then quantified by
the ‘‘Analyze Particle’’ tool of ImageJ software. The number density
and area density of LaNO3 penetrated into the SC layer and the viable
epidermal layers were quantified for control, LFS-treated, tape-
stripped, OA-treated, TS/LFS-treated, and OA/LFS-treated skin samples.
www.jidonline.org 1071
SE Lee et al.
Skin Penetration Pathways by Low-Frequency Sonophoresis
Statistical analysis
To test the significance of LaNO3 penetration properties on
ultrasound treatment, analysis of Student’s t-test (two-tailed hetero-
skedastic test) was applied to the data set.
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